H2R708 (H2R708_PANTR) Pan troglodytes (Chimpanzee)

Splicing factor 3a, subunit 1, 120kDa UniProtKBInterProSTRINGInteractive Modelling

793 aa; Sequence (Fasta) ; 3 identical sequences: Homo sapiens: Q15459; Pan troglodytes: A0A6D2XXC0; Gorilla gorilla gorilla: G3RA68

Available Structures

40 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Cryo-EM structure of human exon-defined spliceosome in the late pre-B state. Heteromer
O43172; O43290; O43395; O75533; O75643; O94906; O95777; P08579; P09661; P14678; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q12874; Q13435; Q13523; Q15029; Q15393; Q15427; Q15428; Q15459; Q53GS9; Q6P2Q9; Q7RTV0; Q8WVK2; Q8WWY3; Q96DI7; Q9BTD8; Q9BUQ8; Q9BWJ5; Q9UK45; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0;
160-530
100.0IHP;MG;GTP;ZN;
Cryo-EM structure of human exon-defined spliceosome in the early B state. Heteromer
O43172; O43290; O43395; O43447; O75533; O75554; O75643; O94906; O95777; P08579; P09661; P14678; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q12874; Q13435; Q15029; Q15393; Q15427; Q15428; Q15459; Q2TAY7; Q6P2Q9; Q7RTV0; Q8WWY3; Q96DI7; Q9BWJ5; Q9UK45; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0;
160-530
100.0IHP;GTP;MG;ZN;
Cryo-EM structure of the cross-exon pre-B+5'ss+ATPgammaS complex Heteromer
O43172; O43290; O43395; O43447; O75533; O75643; O94906; O95777; P08579; P09661; P14678; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q12874; Q13435; Q15029; Q15393; Q15427; Q15428; Q15459; Q53GS9; Q6P2Q9; Q7RTV0; Q8WWY3; Q96DI7; Q9BUQ8; Q9BWJ5; Q9UK45; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0;
160-521
100.0
Cryo-EM structure of the cross-exon pre-B+ATP complex Heteromer
O43172; O43290; O43395; O43447; O75533; O75643; O94906; O95777; P08579; P09661; P14678; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q12874; Q13435; Q15029; Q15393; Q15427; Q15428; Q15459; Q53GS9; Q6P2Q9; Q7RTV0; Q8WWY3; Q96DI7; Q9BUQ8; Q9BWJ5; Q9UK45; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0;
160-521
100.0
Cryo-EM structure of the cross-exon pre-B+5'ss complex Heteromer
O43172; O43290; O43395; O75533; O75643; O94906; O95777; P08579; P09661; P14678; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q12874; Q13435; Q13523; Q15029; Q15393; Q15427; Q15428; Q15459; Q53GS9; Q6P2Q9; Q7RTV0; Q8WVK2; Q8WWY3; Q96DI7; Q9BTD8; Q9BUQ8; Q9BWJ5; Q9UK45; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0;
160-489
100.0
Cryo-EM structure of the cross-exon pre-B+5'ssLNG+ATPyS complex Heteromer
O43172; O43290; O43395; O43447; O75533; O75643; O94906; O95777; P08579; P09661; P14678; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q12874; Q13435; Q15029; Q15393; Q15427; Q15428; Q15459; Q53GS9; Q6P2Q9; Q7RTV0; Q8WWY3; Q96DI7; Q9BUQ8; Q9BWJ5; Q9UK45; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0;
160-489
100.0
Cryo-EM structure of the cross-exon pre-B complex Heteromer
O43172; O43290; O43395; O75533; O75643; O94906; O95777; P08579; P09661; P14678; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q12874; Q13435; Q13523; Q15029; Q15393; Q15427; Q15428; Q15459; Q53GS9; Q6P2Q9; Q7RTV0; Q8WVK2; Q8WWY3; Q96DI7; Q9BTD8; Q9BUQ8; Q9BWJ5; Q9UK45; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0;
160-473
100.0
The cryo-EM structure of human Bact-III complex Heteromer
O15541; O43660; O60231; O60306; O60508; O75533; O75643; O75934; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13356; Q13435; Q13573; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q7RTV0; Q8WUA2; Q96DI7; Q99459; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UMS4; Q9UNP9; Q9UQ35; Q9Y3C6;
47-282
100.0IHP;GTP;MG;ZN;
The cryo-EM structure of human Bact-II complex Heteromer
O15541; O43660; O60231; O60306; O75533; O75643; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13356; Q13435; Q13573; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q7RTV0; Q8WUA2; Q96DI7; Q99459; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UNP9; Q9UQ35; Q9Y3C6;
47-282
100.0IHP;GTP;MG;ZN;
The cryo-EM structure of human pre-Bact complex Heteromer
O43660; O60306; O60870; O75533; O75643; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13356; Q13435; Q13573; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q7RTV0; Q8IYB3; Q8TAD8; Q96DI7; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCS7; Q9NW64; Q9P013; Q9UNP9; Q9Y388; Q9Y3B4;
47-282
100.0GTP;MG;ZN;
The cryo-EM structure of human Bact-I complex Heteromer
O15541; O43660; O60231; O60306; O75533; O75643; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13356; Q13435; Q13573; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q6UX04; Q7RTV0; Q8IYB3; Q8TAD8; Q96DI7; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UNP9; Q9UQ35; Q9Y388; Q9Y3B4;
47-282
100.0IHP;GTP;MG;ZN;
human Bact spliceosome core structure Heteromer
O15541; O43660; O60231; O60306; O60508; O75533; O75643; O75934; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q13573; Q15029; Q15393; Q15428; Q15459; Q6P2Q9; Q6UX04; Q7RTV0; Q8IYB3; Q8TAD8; Q96DI7; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9ULR0; Q9UMS4; Q9UNP9; Q9UQ35; Q9Y388; Q9Y3B4; Q9Y3C6;
47-272
100.011×ZN;MG;IHP;GTP;ADP;
Human pre-Bact-2 spliceosome Heteromer
O43660; O60306; O60508; O60870; O75533; O75643; P08579; P09661; P14678; P41223; P55081; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13356; Q13435; Q13573; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q7RTV0; Q8IYB3; Q8NAV1; Q8TAD8; Q8WYA6; Q96DI7; Q96NC0; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9BZL1; Q9HCS7; Q9NW64; Q9P013; Q9UNP9; Q9Y388; Q9Y3B4;
47-219
100.0GTP;MG;IHP;
Cryo-EM structure of human exon-defined spliceosome in the mature pre-B state. Heteromer
O43172; O43290; O43395; O75533; O75643; O94906; O95777; P08579; P09661; P14678; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q12874; Q13435; Q13523; Q15029; Q15393; Q15427; Q15428; Q15459; Q53GS9; Q6P2Q9; Q7RTV0; Q8WVK2; Q8WWY3; Q96DI7; Q9BTD8; Q9BUQ8; Q9BWJ5; Q9UK45; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0;
160-302
100.0IHP;MG;GTP;ZN;
The Cryo-EM Structure of the Precusor of Human Pre-catalytic Spliceosome (pre-B complex) Heteromer
O43172; O43395; O75533; O75643; O94906; O95777; P08579; P09661; P14678; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q12874; Q13435; Q15029; Q15393; Q15427; Q15428; Q15459; Q53GS9; Q6P2Q9; Q7RTV0; Q8WWY3; Q96DI7; Q9BUQ8; Q9BWJ5; Q9UK45; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0;
160-302
100.0IHP;GTP;MG;
Structure of a late-stage activated spliceosome (BAqr) arrested with a dominant-negative Aquarius m… Heteromer
O15541; O43660; O60231; O60306; O60508; O75533; O75643; O75934; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13356; Q13435; Q13573; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q7RTV0; Q8WUA2; Q92917; Q96DI7; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9ULR0; Q9UMS4; Q9UNP9; Q9UQ35; Q9Y3C6;
160-285
100.012×ZN;IHP;GTP;MG;
Cryo-EM structure of a human activated spliceosome (early Bact) at 4.9 angstrom. Heteromer
O15541; O43660; O60231; O75533; O75643; P08579; P09661; P14678; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q13573; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q6UX04; Q7RTV0; Q8TAD8; Q96DI7; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9P013; Q9Y388; Q9Y3B4;
160-285
100.0IHP;GTP;MG;ZN;
cryo-EM structure of a human activated spliceosome (mature Bact) at 5.1 angstrom. Heteromer
O15541; O43660; O60231; O60306; O60508; O75533; O75643; O75934; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q6UX04; Q7RTV0; Q8TAD8; Q96DI7; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UMS4; Q9UNP9; Q9UQ35; Q9Y388; Q9Y3B4; Q9Y3C6;
160-285
100.0IHP;GTP;MG; 13×ZN;
Cryo-EM structure of the human activated spliceosome (late Bact) at 6.5 angstrom Heteromer
O43660; O60231; O60306; O60508; O75533; O75643; O75934; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q7RTV0; Q8TAD8; Q96DI7; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UMS4; Q9UNP9; Q9UQ35; Q9Y388; Q9Y3B4; Q9Y3C6;
160-285
100.0IHP;ALA;GTP;MG; 10×ZN;
The cryo-EM structure of the human 17S U2 snRNP Heteromer
O43719; O75533; P08579; P09661; P14678; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q15393; Q15427; Q15428; Q15459; Q7L014; Q7RTV0; Q9BWJ5;
160-282
1009B0;ZN;
The cryo-EM structure of human pre-17S U2 snRNP Heteromer
O43719; O75533; P08579; P09661; P14678; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q15393; Q15427; Q15428; Q15459; Q7RTV0; Q86XP3; Q9BWJ5;
160-282
1009B0;ZN;
human 17S U2 snRNP low resolution part Heteromer
O43719; O75533; P08579; P09661; P14678; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q15427; Q15428; Q15459; Q7L014; Q9Y3B4;
160-282
100
human 17S U2 snRNP Heteromer
O43719; O75533; P08579; P09661; P14678; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q15393; Q15427; Q15428; Q15459; Q7L014; Q7RTV0; Q9BWJ5; Q9Y3B4;
160-282
100
The cryo-EM structure of the human pre-A complex Heteromer
O75533; O75937; P08579; P08621; P09012; P09234; P09661; P14678; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q15393; Q15427; Q15428; Q15459; Q15637; Q7L014; Q7RTV0; Q9BWJ5;
160-282
100ZN;SJT;
Cryo-EM Structure of Pre-B+5'ss+ATPgammaS Complex (core part) Heteromer
O43172; O43290; O43395; O75643; O94906; P55769; P83876; Q15029; Q15459; Q53GS9; Q6P2Q9; Q8WWY3; Q9BUQ8;
409-521
100.0IHP;
Cryo-EM Structure of Pre-B+ATP Complex (core part) Heteromer
O43172; O43290; O43395; O75643; O94906; P55769; P83876; Q15029; Q15459; Q53GS9; Q6P2Q9; Q8WWY3; Q9BUQ8;
409-521
100.0IHP;
Solution structure of the second SURP domain of human splicing factor SF3a120 in complex with a fra… Heteromer
Q12874; Q15459;
134-217
100
Cryo-EM Structure of Pre-B-like Complex (core part) Heteromer
O43172; O43290; O43395; O75554; O94906; P55081; P55769; P83876; Q15029; Q15459; Q53GS9; Q6P2Q9; Q8NAV1; Q8WWY3; Q96NC0;
409-489
100IHP;
Cryo-EM Structure of Pre-B+5'ssLNG Complex (core part) Heteromer
O43172; O43290; O43395; O75643; O94906; P55769; P83876; Q15029; Q15459; Q53GS9; Q6P2Q9; Q8WWY3; Q9BUQ8;
409-489
100IHP;
cryo-EM structure of the human spliceosomal B complex protomer (tri-snRNP core region) Heteromer
O14776; O43172; O43290; O43395; O75554; O94906; P41223; P55081; P55769; P83876; Q15029; Q15459; Q6P2Q9; Q8NAV1; Q8WWY3; Q96NC0; Q9BZL1;
409-489
100
Human pre-Bact-1 spliceosome Heteromer
O14776; O43660; O75533; O75643; O95777; P08579; P09661; P14678; P41223; P52298; P55081; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; Q07955; Q09161; Q12874; Q13435; Q13573; Q15029; Q15393; Q15427; Q15428; Q15459; Q6P2Q9; Q7RTV0; Q8IYB3; Q8NAV1; Q8TAD8; Q96DI7; Q96NC0; Q99459; Q9BWJ5; Q9BZL1; Q9NW64; Q9P013; Q9UK45; Q9Y2W2; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0;
160-219
100IHP;GTP;MG;GTG;
Cryo-EM Structure of Pre-B+5'ss Complex (core part) Heteromer
O43290; O75643; O94906; P83876; Q15029; Q15459; Q53GS9; Q6P2Q9; Q8WVK2; Q8WWY3; Q9BTD8; Q9BUQ8;
454-489
100IHP;
Cryo-EM Structure of Pre-B Complex (core part) Heteromer
O43290; O43395; O94906; P83876; Q15029; Q15459; Q53GS9; Q6P2Q9; Q8WVK2; Q8WWY3; Q9BTD8; Q9BUQ8;
461-473
100IHP;
Cryo-EM Structure of Pre-B+AMPPNP Complex (core part) Heteromer
O43290; O43395; O75643; O94906; P83876; Q15029; Q15459; Q53GS9; Q6P2Q9; Q8WVK2; Q8WWY3; Q9BTD8; Q9BUQ8;
461-473
100IHP;
Crystal structure of the ubiquitin-like domain in the SF3A1 subunit of human U2 snRNP complexed wit…homo-2-mer703-793
100
Solution structure of the human SF3A1 ubiquitin-like domainmonomer704-793
100
Crystal structure of human SF3A1 ubiquitin-like domain in complex with U1 snRNA stem-loop 4monomer704-791
1001PE;NA;
Solution structure of a human ubiquitin-like domain in SF3A1monomer704-789
100
Solution structure of the first SURP domain of human splicing factor SF3a120monomer48-110
100
Solution structure of the chimeric peptide of the first SURP domain of Human SF3A1 and the interact…monomer48-110
100

5 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7abi.1.kmonomer0.6347-219
100.00
6ff7.1.umonomer0.6147-272
100.00
7zh3.1.Amonomer0.58707-790
28.95
8qpb.1.Nmonomer0.55409-521
100.00
8h6e.1.imonomer0.52160-530
100.00